Thomas S Dexheimer

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Small Cell Lung Cancer

Palliative Care

Top Venues

Cancer research

Cancer research communications

Science translational medicine

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research 84 (15) (2024)
Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research 84 (15) (2024)
Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research 84 (15) (2024)
Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research (2024)
Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research 84 (15) (2024)
Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, John J Wright, Joel Morris, James H Doroshow, Beverly A Teicher
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs. Cancer research communications 3 (8) (2023)
Joel Morris, Mark W Kunkel, Stephen L White, Donn G Wishka, Omar D Lopez, Lori Bowles, Penny Sellers Brady, Patricia Ramsey, Julie Grams, Tiffany Rohrer, Karen Martin, Thomas S Dexheimer, Nathan P Coussens, David M Evans, Prabhakar Risbood, Dmitriy Sonkin, John D Williams, Eric C Polley, Jerry M Collins, James H Doroshow, Beverly A Teicher
Targeted Investigational Oncology Agents (IOA) in the NCI60: A Phenotypic Systems-Based Resource. Molecular cancer therapeutics (2023)
William C Stafford, Xiaoxiao Peng, Maria Hägg Olofsson, Xiaonan Zhang, Diane K Luci, Li Lu, Qing Cheng, Lionel Trésaugues, Thomas S Dexheimer, Nathan P Coussens, Martin Augsten, Hanna-Stina Martinsson Ahlzén, Owe Orwar, Arne Östman, Sharon Stone-Elander, David J Maloney, Ajit Jadhav, Anton Simeonov, Stig Linder, Elias S J Arnér
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Science translational medicine 10 (428) (2019)